LABCEUTICS LTD

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  —

  Not reported

• Cash

  -0.2%

  £50,120 → £50,000

• Net assets

  -0.4%

  -£50,540 → -£50,753

• Employees

  —

  Not reported

• Profit before tax

  -107.4%

  £2,882 → -£213

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

Ernst & Young

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The directors are aware that the company is dependent on its parent company, Diaceutics PLC, for funding and the parent company has the ability to provide this funding if required. The directors believe that preparing the financial statements on a going concern basis is appropriate due to the continued financial support of the parent undertaking (Diaceutics PLC). The directors have received confirmation that Diaceutics PLC intends to support the company for at least 12 months after these financial statements are signed.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

2

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.